Kawaguchi Chemical IndustryKawaguchi Chemical Industry Co., Ltd4361東証スタンダード化学FY ending Nov 2025, consolidated, J-GAAP
Revenue by business segment, and the profit each one keeps.
Geographic revenue reported in annual filings
No geographic revenue breakdown was disclosed.
※ Segment figures include inter-segment sales and do not sum to the company total
X-axis: segment revenue CAGR. Y-axis: latest operating margin. Bubble size: revenue.
Bubble size represents latest revenue. Segments without a CAGR are placed at the left edge; their horizontal position is not a growth value. Color indicates positive or negative margin.
| Segment | Revenue CAGR | FY ending Nov 2021 | FY ending Nov 2022 | FY ending Nov 2023 | FY ending Nov 2024 | FY ending Nov 2025 |
|---|---|---|---|---|---|---|
| Pharmaceutical products | +5.9%5y | 7,9014.4% | 8,3303.2% | 8,5723.8% | 8,8823.9% | 8,7764.5% |
| Real estate leasing | +0.2%5y | 3880.0% | 3880.0% | 3880.1% | 3880.2% | 3879.8% |
Top: revenue. Bottom: operating margin.
EDINET (FSA Japan)
有価証券報告書－第124期(2024/12/01－2025/11/30)
EDINET (FSA Japan)
有価証券報告書－第123期(2023/12/01－2024/11/30)
EDINET (FSA Japan)
有価証券報告書－第122期(2022/12/01－2023/11/30)
EDINET (FSA Japan)
有価証券報告書－第121期(2021/12/01－2022/11/30)
EDINET (FSA Japan)
有価証券報告書－第120期(令和2年12月1日－令和3年11月30日)
EDINET (FSA Japan)
有価証券報告書－第119期(令和1年12月1日－令和2年11月30日)
Extracted from XBRL: 48 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.